0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Injectable Targeted Therapy Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-9C13979
Home | Market Reports | Health| Nursing
Global Injectable Targeted Therapy Market Research Report 2023
BUY CHAPTERS

Global Injectable Targeted Therapy Market Research Report 2025

Code: QYRE-Auto-9C13979
Report
September 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Injectable Targeted Therapy Market

The global market for Injectable Targeted Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Will affect the normal tissue cells around the tumor.
North American market for Injectable Targeted Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Injectable Targeted Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Injectable Targeted Therapy in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Injectable Targeted Therapy include Novartis, Sanofi, GSK, Bayer, Amgen, Merck, AbbiVie, AstraZeneca, Teva, Roche, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Injectable Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Targeted Therapy.
The Injectable Targeted Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injectable Targeted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Targeted Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Injectable Targeted Therapy Market Report

Report Metric Details
Report Name Injectable Targeted Therapy Market
Segment by Type
  • Monoclonal Antibodies
  • Small-Molecules
  • Immunotoxins
  • Others
Segment by Application
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Sanofi, GSK, Bayer, Amgen, Merck, AbbiVie, AstraZeneca, Teva, Roche, Pfizer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Injectable Targeted Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Injectable Targeted Therapy Market report?

Ans: The main players in the Injectable Targeted Therapy Market are Novartis, Sanofi, GSK, Bayer, Amgen, Merck, AbbiVie, AstraZeneca, Teva, Roche, Pfizer

What are the Application segmentation covered in the Injectable Targeted Therapy Market report?

Ans: The Applications covered in the Injectable Targeted Therapy Market report are Hospitals, Homecare, Specialty Clinics, Others

What are the Type segmentation covered in the Injectable Targeted Therapy Market report?

Ans: The Types covered in the Injectable Targeted Therapy Market report are Monoclonal Antibodies, Small-Molecules, Immunotoxins, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Targeted Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Small-Molecules
1.2.4 Immunotoxins
1.2.5 Others
1.3 Market by Application
1.3.1 Global Injectable Targeted Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Injectable Targeted Therapy Market Perspective (2020-2031)
2.2 Global Injectable Targeted Therapy Growth Trends by Region
2.2.1 Global Injectable Targeted Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Injectable Targeted Therapy Historic Market Size by Region (2020-2025)
2.2.3 Injectable Targeted Therapy Forecasted Market Size by Region (2026-2031)
2.3 Injectable Targeted Therapy Market Dynamics
2.3.1 Injectable Targeted Therapy Industry Trends
2.3.2 Injectable Targeted Therapy Market Drivers
2.3.3 Injectable Targeted Therapy Market Challenges
2.3.4 Injectable Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable Targeted Therapy Players by Revenue
3.1.1 Global Top Injectable Targeted Therapy Players by Revenue (2020-2025)
3.1.2 Global Injectable Targeted Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Injectable Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Injectable Targeted Therapy Revenue
3.4 Global Injectable Targeted Therapy Market Concentration Ratio
3.4.1 Global Injectable Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Targeted Therapy Revenue in 2024
3.5 Global Key Players of Injectable Targeted Therapy Head office and Area Served
3.6 Global Key Players of Injectable Targeted Therapy, Product and Application
3.7 Global Key Players of Injectable Targeted Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Targeted Therapy Breakdown Data by Type
4.1 Global Injectable Targeted Therapy Historic Market Size by Type (2020-2025)
4.2 Global Injectable Targeted Therapy Forecasted Market Size by Type (2026-2031)
5 Injectable Targeted Therapy Breakdown Data by Application
5.1 Global Injectable Targeted Therapy Historic Market Size by Application (2020-2025)
5.2 Global Injectable Targeted Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Injectable Targeted Therapy Market Size (2020-2031)
6.2 North America Injectable Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Injectable Targeted Therapy Market Size by Country (2020-2025)
6.4 North America Injectable Targeted Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Injectable Targeted Therapy Market Size (2020-2031)
7.2 Europe Injectable Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Injectable Targeted Therapy Market Size by Country (2020-2025)
7.4 Europe Injectable Targeted Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable Targeted Therapy Market Size (2020-2031)
8.2 Asia-Pacific Injectable Targeted Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Injectable Targeted Therapy Market Size (2020-2031)
9.2 Latin America Injectable Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Injectable Targeted Therapy Market Size by Country (2020-2025)
9.4 Latin America Injectable Targeted Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable Targeted Therapy Market Size (2020-2031)
10.2 Middle East & Africa Injectable Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Injectable Targeted Therapy Introduction
11.1.4 Novartis Revenue in Injectable Targeted Therapy Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Injectable Targeted Therapy Introduction
11.2.4 Sanofi Revenue in Injectable Targeted Therapy Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Injectable Targeted Therapy Introduction
11.3.4 GSK Revenue in Injectable Targeted Therapy Business (2020-2025)
11.3.5 GSK Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Injectable Targeted Therapy Introduction
11.4.4 Bayer Revenue in Injectable Targeted Therapy Business (2020-2025)
11.4.5 Bayer Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Injectable Targeted Therapy Introduction
11.5.4 Amgen Revenue in Injectable Targeted Therapy Business (2020-2025)
11.5.5 Amgen Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Injectable Targeted Therapy Introduction
11.6.4 Merck Revenue in Injectable Targeted Therapy Business (2020-2025)
11.6.5 Merck Recent Development
11.7 AbbiVie
11.7.1 AbbiVie Company Details
11.7.2 AbbiVie Business Overview
11.7.3 AbbiVie Injectable Targeted Therapy Introduction
11.7.4 AbbiVie Revenue in Injectable Targeted Therapy Business (2020-2025)
11.7.5 AbbiVie Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Injectable Targeted Therapy Introduction
11.8.4 AstraZeneca Revenue in Injectable Targeted Therapy Business (2020-2025)
11.8.5 AstraZeneca Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Injectable Targeted Therapy Introduction
11.9.4 Teva Revenue in Injectable Targeted Therapy Business (2020-2025)
11.9.5 Teva Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Injectable Targeted Therapy Introduction
11.10.4 Roche Revenue in Injectable Targeted Therapy Business (2020-2025)
11.10.5 Roche Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Injectable Targeted Therapy Introduction
11.11.4 Pfizer Revenue in Injectable Targeted Therapy Business (2020-2025)
11.11.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Injectable Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoclonal Antibodies
 Table 3. Key Players of Small-Molecules
 Table 4. Key Players of Immunotoxins
 Table 5. Key Players of Others
 Table 6. Global Injectable Targeted Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Injectable Targeted Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Injectable Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Injectable Targeted Therapy Market Share by Region (2020-2025)
 Table 10. Global Injectable Targeted Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Injectable Targeted Therapy Market Share by Region (2026-2031)
 Table 12. Injectable Targeted Therapy Market Trends
 Table 13. Injectable Targeted Therapy Market Drivers
 Table 14. Injectable Targeted Therapy Market Challenges
 Table 15. Injectable Targeted Therapy Market Restraints
 Table 16. Global Injectable Targeted Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Injectable Targeted Therapy Market Share by Players (2020-2025)
 Table 18. Global Top Injectable Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Targeted Therapy as of 2024)
 Table 19. Ranking of Global Top Injectable Targeted Therapy Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Injectable Targeted Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Injectable Targeted Therapy, Headquarters and Area Served
 Table 22. Global Key Players of Injectable Targeted Therapy, Product and Application
 Table 23. Global Key Players of Injectable Targeted Therapy, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Injectable Targeted Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Injectable Targeted Therapy Revenue Market Share by Type (2020-2025)
 Table 27. Global Injectable Targeted Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Injectable Targeted Therapy Revenue Market Share by Type (2026-2031)
 Table 29. Global Injectable Targeted Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Injectable Targeted Therapy Revenue Market Share by Application (2020-2025)
 Table 31. Global Injectable Targeted Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Injectable Targeted Therapy Revenue Market Share by Application (2026-2031)
 Table 33. North America Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Injectable Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Injectable Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Injectable Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Injectable Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Injectable Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Injectable Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Injectable Targeted Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Injectable Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Injectable Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Injectable Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Injectable Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Novartis Company Details
 Table 49. Novartis Business Overview
 Table 50. Novartis Injectable Targeted Therapy Product
 Table 51. Novartis Revenue in Injectable Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 52. Novartis Recent Development
 Table 53. Sanofi Company Details
 Table 54. Sanofi Business Overview
 Table 55. Sanofi Injectable Targeted Therapy Product
 Table 56. Sanofi Revenue in Injectable Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 57. Sanofi Recent Development
 Table 58. GSK Company Details
 Table 59. GSK Business Overview
 Table 60. GSK Injectable Targeted Therapy Product
 Table 61. GSK Revenue in Injectable Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 62. GSK Recent Development
 Table 63. Bayer Company Details
 Table 64. Bayer Business Overview
 Table 65. Bayer Injectable Targeted Therapy Product
 Table 66. Bayer Revenue in Injectable Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 67. Bayer Recent Development
 Table 68. Amgen Company Details
 Table 69. Amgen Business Overview
 Table 70. Amgen Injectable Targeted Therapy Product
 Table 71. Amgen Revenue in Injectable Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 72. Amgen Recent Development
 Table 73. Merck Company Details
 Table 74. Merck Business Overview
 Table 75. Merck Injectable Targeted Therapy Product
 Table 76. Merck Revenue in Injectable Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 77. Merck Recent Development
 Table 78. AbbiVie Company Details
 Table 79. AbbiVie Business Overview
 Table 80. AbbiVie Injectable Targeted Therapy Product
 Table 81. AbbiVie Revenue in Injectable Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 82. AbbiVie Recent Development
 Table 83. AstraZeneca Company Details
 Table 84. AstraZeneca Business Overview
 Table 85. AstraZeneca Injectable Targeted Therapy Product
 Table 86. AstraZeneca Revenue in Injectable Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 87. AstraZeneca Recent Development
 Table 88. Teva Company Details
 Table 89. Teva Business Overview
 Table 90. Teva Injectable Targeted Therapy Product
 Table 91. Teva Revenue in Injectable Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 92. Teva Recent Development
 Table 93. Roche Company Details
 Table 94. Roche Business Overview
 Table 95. Roche Injectable Targeted Therapy Product
 Table 96. Roche Revenue in Injectable Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 97. Roche Recent Development
 Table 98. Pfizer Company Details
 Table 99. Pfizer Business Overview
 Table 100. Pfizer Injectable Targeted Therapy Product
 Table 101. Pfizer Revenue in Injectable Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 102. Pfizer Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Injectable Targeted Therapy Picture
 Figure 2. Global Injectable Targeted Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Injectable Targeted Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Monoclonal Antibodies Features
 Figure 5. Small-Molecules Features
 Figure 6. Immunotoxins Features
 Figure 7. Others Features
 Figure 8. Global Injectable Targeted Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Injectable Targeted Therapy Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Homecare Case Studies
 Figure 12. Specialty Clinics Case Studies
 Figure 13. Others Case Studies
 Figure 14. Injectable Targeted Therapy Report Years Considered
 Figure 15. Global Injectable Targeted Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Injectable Targeted Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Injectable Targeted Therapy Market Share by Region: 2024 VS 2031
 Figure 18. Global Injectable Targeted Therapy Market Share by Players in 2024
 Figure 19. Global Top Injectable Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Targeted Therapy as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Injectable Targeted Therapy Revenue in 2024
 Figure 21. North America Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Injectable Targeted Therapy Market Share by Country (2020-2031)
 Figure 23. United States Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Injectable Targeted Therapy Market Share by Country (2020-2031)
 Figure 27. Germany Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Injectable Targeted Therapy Market Share by Region (2020-2031)
 Figure 35. China Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Injectable Targeted Therapy Market Share by Country (2020-2031)
 Figure 43. Mexico Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Injectable Targeted Therapy Market Share by Country (2020-2031)
 Figure 47. Turkey Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Injectable Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Novartis Revenue Growth Rate in Injectable Targeted Therapy Business (2020-2025)
 Figure 51. Sanofi Revenue Growth Rate in Injectable Targeted Therapy Business (2020-2025)
 Figure 52. GSK Revenue Growth Rate in Injectable Targeted Therapy Business (2020-2025)
 Figure 53. Bayer Revenue Growth Rate in Injectable Targeted Therapy Business (2020-2025)
 Figure 54. Amgen Revenue Growth Rate in Injectable Targeted Therapy Business (2020-2025)
 Figure 55. Merck Revenue Growth Rate in Injectable Targeted Therapy Business (2020-2025)
 Figure 56. AbbiVie Revenue Growth Rate in Injectable Targeted Therapy Business (2020-2025)
 Figure 57. AstraZeneca Revenue Growth Rate in Injectable Targeted Therapy Business (2020-2025)
 Figure 58. Teva Revenue Growth Rate in Injectable Targeted Therapy Business (2020-2025)
 Figure 59. Roche Revenue Growth Rate in Injectable Targeted Therapy Business (2020-2025)
 Figure 60. Pfizer Revenue Growth Rate in Injectable Targeted Therapy Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart